For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Childhood BMI trends — specifically moderate BMI and high BMI variability — were associated with high cortisol concentrations at 17 years of age.

From 1999 to 2021, methamphetamine-related mortality surged dramatically, with a significant rise in heroin and synthetic opioid coinvolvement.

Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.